Resistant cancer

Resistant cancer is a term used to describe cancer types that do not respond to standard treatments. This resistance can be inherent or acquired. Inherent resistance refers to the natural ability of certain cancers to resist treatment, while acquired resistance develops over time due to the adaptation of cancer cells to the treatments used.

Causes

The causes of resistant cancer are complex and multifactorial. They can be broadly divided into two categories: tumor cell-intrinsic factors and tumor microenvironment factors.

Tumor cell-intrinsic factors

These factors are related to the genetic and epigenetic changes in the cancer cells themselves. They include mutations, gene amplification, and epigenetic changes that lead to the overexpression of drug efflux pumps, alterations in drug targets, and defects in cell death pathways.

Tumor microenvironment factors

These factors are related to the physical and biochemical environment in which the tumor cells reside. They include hypoxia, acidic pH, and the presence of stromal cells and immune cells that can protect the tumor cells from the effects of treatment.

Treatment

The treatment of resistant cancer is challenging and often requires a multidisciplinary approach. This may include the use of chemotherapeutic agents that are not cross-resistant with the initial treatment, the use of radiation, surgery, and/or immunotherapy. In some cases, clinical trials of new drugs or treatment strategies may be an option.

Research

Research into resistant cancer is ongoing and focuses on understanding the mechanisms of resistance and developing new strategies to overcome it. This includes the development of new drugs that can target the specific genetic and epigenetic changes in resistant cancer cells, as well as strategies to modulate the tumor microenvironment to make it less conducive to resistance.

See also

• Cancer
• Chemotherapy
• Radiation therapy
• Immunotherapy
• Clinical trial